Insider · CIK 0001997710
Janet Jill Hopkins
Files at AURA (Aura Biosciences, Inc.). First filing Nov 18, 2024, latest Feb 17, 2026.
In brief
Janet Jill Hopkins files SEC Form 4 as officer at AURA (Aura Biosciences, Inc.). Since Nov 18, 2024, Janet Jill Hopkins has reported 0 open-market buys worth $0 and 4 open-market sells worth $326k, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Janet Jill Hopkins has 0, so none is measured yet.
The newest scored trade: sold $103k of AURA on Feb 17, 2026, filed Feb 17, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $196k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURA: Aura Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Aura Biosciences, Inc. | $103k 20,401 shares | -8% | +7% from low-31% from high | |
| 25Weak | AURAsell Aura Biosciences, Inc. | $93k 17,109 shares | -6% | +12% from low-41% from high | |
| 30Weak | Aura Biosciences, Inc. | $20k 2,534 shares | -1% | - | |
| 25Weak | AURAsell Aura Biosciences, Inc. | $111k 11,822 shares | -7% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | 20,401 0.03% of outstanding | $103k | Feb 17, 2026 | $93k |
| Nov 17, 2025 | AURA Aura Biosciences, Inc. | 17,109 0.03% of outstanding | $93k | Nov 17, 2025 | none |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | 2,534 0.01% of outstanding | $20k | Feb 18, 2025 | $111k |
| Nov 18, 2024 | AURA Aura Biosciences, Inc. | 11,822 0.02% of outstanding | $111k | Nov 18, 2024 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +58,850 | $0.00 | $0 | 380,190 | 43 d ago |
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +116,150 | $0.00 | $0 | 116,150 | 43 d ago |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +89,056 | $0.00 | $0 | 321,340 | Mar 3, 2026 |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +160,944 | $0.00 | $0 | 160,944 | Mar 3, 2026 |
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -20,401 | $5.06 | $103k | 232,284 | Feb 17, 2026 |
| Nov 17, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -17,109 | $5.42 | $93k | 252,685 | Nov 17, 2025 |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -2,534 | $7.75 | $20k | 269,794 | Feb 18, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +120,635 | $0.00 | $0 | 272,328 | Feb 4, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +79,365 | $0.00 | $0 | 79,365 | Feb 4, 2025 |
| Nov 18, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -11,822 | $9.36 | $111k | 151,693 | Nov 18, 2024 |
| Feb 1, 2024 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +28,515 | $0.00 | $0 | 163,515 | Feb 2, 2024 |
| Feb 1, 2024 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +41,485 | $0.00 | $0 | 41,485 | Feb 2, 2024 |
| Nov 1, 2023 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +135,000 | $0.00 | $0 | 135,000 | Nov 3, 2023 |
| Nov 1, 2023 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Nov 3, 2023 |
Questions about Janet Jill Hopkins
Answered from the filings on this page, as of the latest one.
Is Janet Jill Hopkins buying or selling?
In the last 12 months Janet Jill Hopkins reported 0 open-market buys worth $0 and 2 open-market sells worth $196k on SEC Form 4; the latest was sold $103k of AURA on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Janet Jill Hopkins's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Janet Jill Hopkins has 0.
Where does Janet Jill Hopkins file Form 4?
Janet Jill Hopkins has filed Form 4 at AURA (Aura Biosciences, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.